(Q59245656)

12 December 2020

Flavivirus genome organization, expression, and replication

1 reference

12 December 2020

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

1 reference

12 December 2020

Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

1 reference

12 December 2020

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

12 December 2020

A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization

1 reference

12 December 2020

Japanese encephalitis vaccines: current vaccines and future prospects

1 reference

12 December 2020

Intracellular Assembly and Secretion of Recombinant Subviral Particles from Tick-Borne Encephalitis Virus

1 reference

12 December 2020

Zika virus infection experimentally induced in a human volunteer

1 reference

12 December 2020

ZIKA VIRUS INFECTION IN MAN.

1 reference

12 December 2020

Molecular biology of flaviviruses

1 reference

12 December 2020

mRNA is an endogenous ligand for Toll-like receptor 3.

1 reference

12 December 2020

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

1 reference

12 December 2020

Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses

1 reference

12 December 2020

Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).

1 reference

12 December 2020

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

1 reference

12 December 2020

Zika virus outside Africa

1 reference

12 December 2020

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

1 reference

12 December 2020

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

1 reference

12 December 2020

Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice

1 reference

12 December 2020

Zika virus genome from the Americas

1 reference

12 December 2020

Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth

1 reference

12 December 2020

Zika virus: History, emergence, biology, and prospects for control

1 reference

12 December 2020

Vaccine protection against Zika virus from Brazil

1 reference

12 December 2020

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

1 reference

12 December 2020

Rapid development of a DNA vaccine for Zika virus

1 reference

12 December 2020

The flavivirus capsid protein: Structure, function and perspectives towards drug design

1 reference

12 December 2020

Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain–Barré Syndrome: Systematic Review

1 reference

12 December 2020

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

1 reference

12 December 2020

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis

1 reference

12 December 2020

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine

1 reference

12 December 2020

Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day

1 reference

12 December 2020

Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity

1 reference

12 December 2020

An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model

1 reference

12 December 2020

Modified mRNA Vaccines Protect against Zika Virus Infection

1 reference

12 December 2020

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

1 reference

12 December 2020

Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

1 reference

12 December 2020

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models

1 reference

12 December 2020

Protective efficacy of Zika vaccine in AG129 mouse model

1 reference

12 December 2020

Zika virus-like particle (VLP) based vaccine

1 reference

12 December 2020

An update on Zika vaccine developments

1 reference

12 December 2020

Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus

1 reference

12 December 2020

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

1 reference

12 December 2020

Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice

1 reference

12 December 2020

Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus

1 reference

12 December 2020

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice

1 reference

12 December 2020

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage

1 reference

12 December 2020

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

1 reference

12 December 2020

Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins

1 reference

12 December 2020

Functional Analysis of Glycosylation of Zika Virus Envelope Protein

1 reference

12 December 2020

High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks

1 reference

12 December 2020

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

1 reference

12 December 2020

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

1 reference

12 December 2020

In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine

1 reference

12 December 2020

Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge

1 reference

12 December 2020

Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage

1 reference

12 December 2020

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice

1 reference

12 December 2020

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses

1 reference

12 December 2020

Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.

1 reference

12 December 2020

Zika virus like particles elicit protective antibodies in mice

1 reference

12 December 2020

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone

1 reference

12 December 2020

Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.

1 reference

12 December 2020

A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.

1 reference

12 December 2020

Evaluating Vaccination Strategies for Zika Virus in the Americas.

1 reference

12 December 2020

Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection.

1 reference

12 December 2020

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials

1 reference

12 December 2020

Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.

1 reference

12 December 2020

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

1 reference

12 December 2020

A VSV-based Zika virus vaccine protects mice from lethal challenge

1 reference

12 December 2020

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein

1 reference

12 December 2020

E90 subunit vaccine protects mice from Zika virus infection and microcephaly

1 reference

12 December 2020

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge

1 reference

12 December 2020

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity

1 reference

12 December 2020